Workflow
Fuerjia Technology(301371)
icon
Search documents
敷尔佳:目前已在哈尔滨、上海两地布局研发中心,构建了具备区域协同能力的研发体系
Mei Ri Jing Ji Xin Wen· 2025-09-24 07:34
每经AI快讯,有投资者在投资者互动平台提问:公司会不会借助哈工大毕业学生的优势组建新的团队 +公司资金,在科技自动化、信息化方面发力? (记者 王瀚黎) 敷尔佳(301371.SZ)9月24日在投资者互动平台表示,公司目前已在哈尔滨、上海两地布局研发中心, 构建了具备区域协同能力的研发体系。现阶段,公司研发团队规模还处于稳步扩张阶段,核心技术人才 梯队建设将持续推进。未来,公司将进一步加大高端研发人才的引进与培养力度,通过优化人才结构、 完善培养机制等举措提升团队专业素养与创新能力,进而全面强化公司核心研发实力,为技术突破与产 品迭代提供坚实支撑。感谢您的宝贵建议,我们将结合公司实际情况纳入发展考量,持续推动研发体系 的高质量发展。 ...
敷尔佳9月23日获融资买入499.74万元,融资余额1.01亿元
Xin Lang Cai Jing· 2025-09-24 01:40
分红方面,敷尔佳A股上市后累计派现10.00亿元。 机构持仓方面,截止2025年6月30日,敷尔佳十大流通股东中,华宝中证医疗ETF(512170)位居第二 大流通股东,持股254.87万股,相比上期增加65.57万股。南方中证1000ETF(512100)位居第五大流通 股东,持股72.17万股,相比上期增加28.86万股。广发养老指数A(000968)位居第六大流通股东,持 股70.60万股,为新进股东。华夏中证1000ETF(159845)位居第九大流通股东,持股42.27万股,为新 进股东。香港中央结算有限公司退出十大流通股东之列。 资料显示,哈尔滨敷尔佳科技股份有限公司位于黑龙江省哈尔滨市松北区美谷路500号,成立日期2017 年11月28日,上市日期2023年8月1日,公司主营业务涉及从事专业皮肤护理产品的研发、生产和销售的 公司。主营业务收入构成为:化妆品72.39%,医疗器械27.61%。 截至9月19日,敷尔佳股东户数1.50万,较上期减少5.99%;人均流通股5166股,较上期增加6.37%。 2025年1月-6月,敷尔佳实现营业收入8.63亿元,同比减少8.15%;归母净利润2.30亿元 ...
敷尔佳:今年第二季度营业收入环比增长86.68%
Zheng Quan Ri Bao Wang· 2025-09-23 12:40
证券日报网讯敷尔佳(301371)9月23日发布公告,在公司回答调研者提问时表示,销售渠道优化工作 是持续、动态开展的,上半年已取得阶段性进展,销售渠道逐渐回归健康,今年第二季度营业收入环比 增长86.68%,业绩呈回暖趋势,进展符合公司预期。 ...
敷尔佳:公司产品主要分为医疗器械类产品与功能性护肤品两大类
Zheng Quan Ri Bao· 2025-09-23 12:39
Core Viewpoint - The company, Fulejia, announced on September 23 that its products are primarily divided into two categories: medical devices and functional skincare products, featuring a diverse range of formulations including masks, waters, serums, lotions, sprays, single-use products, and eye masks [2] Group 1 - The company offers a wide variety of product forms, which enhances its market coverage [2] - The product categories include both medical devices and functional skincare, indicating a diversified product portfolio [2]
敷尔佳:公司通过加深与京东之间的合作,丰富了京东平台的产品种类
Zheng Quan Ri Bao· 2025-09-23 12:39
(文章来源:证券日报) 证券日报网讯敷尔佳9月23日发布公告,在公司回答调研者提问时表示,目前看,上半年比较亮眼的是 京东,公司通过加深与京东之间的合作,丰富了京东平台的产品种类,增加了一些新的合作方式,例 如:满赠活动、新品首发等,通过双方的紧密合作,共同努力,实现了京东平台的较好增长。 ...
敷尔佳:目前公司重组三型人源化胶原蛋白冻干纤维临床试验的三轮注射已全部完成
Zheng Quan Ri Bao· 2025-09-23 12:37
证券日报网讯敷尔佳9月23日发布公告,在公司回答调研者提问时表示,目前公司重组三型人源化胶原 蛋白冻干纤维临床试验的三轮注射已全部完成,项目处于数据清理与总结报告筹备阶段,进展顺利,符 合公司预期。 (文章来源:证券日报) ...
敷尔佳:上半年乳糖酸面膜的销量符合公司预期
Zheng Quan Ri Bao· 2025-09-23 12:36
(文章来源:证券日报) 证券日报网讯敷尔佳9月23日发布公告,在公司回答调研者提问时表示,从上半年销售数据看,乳糖酸 面膜的销量非常好,符合公司预期。 ...
敷尔佳(301371) - 2025年9月23日投资者关系活动记录表
2025-09-23 09:44
Group 1: Sales Performance - The company's sales channel optimization has shown significant progress, with a 86.68% increase in revenue from Q1 to Q2 2025, indicating a recovery trend that aligns with company expectations [1] - The lactose acid mask launched in August last year has performed very well in sales during the first half of 2025, meeting company expectations [2] Group 2: Product Structure and Development - The company's product range includes medical devices and functional skincare products, featuring various forms such as masks, essences, lotions, and sprays [1] - The company has a robust pipeline of research projects, with ongoing efforts to enhance R&D capabilities following the establishment of a new R&D center in Shanghai [2] Group 3: Online Sales Channels - JD.com has emerged as a strong online sales channel, with the company enhancing its collaboration with JD to diversify product offerings and implement new promotional strategies, resulting in notable growth on the platform [2] Group 4: Future Plans - The company plans to continue launching new products in the upcoming quarters, with specific details to be announced in future communications [2] - Dividend arrangements for the third quarter are still under consideration, with updates to be provided through official announcements [2]
敷尔佳最新股东户数环比下降5.99%
证券时报·数据宝统计,截至发稿,敷尔佳收盘价为25.05元,下跌0.79%,本期筹码集中以来股价累计 下跌5.29%。具体到各交易日,2次上涨,6次下跌。 机构评级来看,近一个月该股获5家机构买入评级。预计目标价最高的是中金公司,8月22日中金公司发 布的研报给予公司目标价33.10元。(数据宝) 注:本文系新闻报道,不构成投资建议,股市有风险,投资需谨慎。 敷尔佳9月22日披露,截至9月20日公司股东户数为15007户,较上期(9月10日)减少956户,环比降幅 为5.99%。 融资融券数据显示,该股最新(9月19日)两融余额为1.01亿元,其中,融资余额为1.01亿元,本期筹码 集中以来融资余额合计减少480.14万元,降幅为4.55%。 公司发布的半年报数据显示,上半年公司共实现营业收入8.63亿元,同比下降8.15%,实现净利润2.30 亿元,同比下降32.54%,基本每股收益为0.4400元,加权平均净资产收益率4.02%。 (文章来源:证券时报网) ...
敷尔佳冷观察:从“管控价格”到“守护价值”的系统性思考
Jin Tou Wang· 2025-09-17 07:29
Group 1 - The core value of the brand Fulejia lies in the professionalism and reliability of its product efficacy, and price fluctuations can dilute consumer perception of value, leading to irreversible damage to the brand [1] - Fulejia's pricing strategy adheres to the "value anchoring" principle, basing its pricing on substantial factors such as R&D investment, clinical trial data, and raw material costs, while addressing the core needs of its target consumer group [1] - The brand maintains a stable pricing system for its flagship product, "Clear Acne Skin Repair Patch," despite multiple formula upgrades, ensuring consumers perceive a direct correlation between price and visible efficacy [1] Group 2 - During promotional events, the stability of Fulejia's regular prices and the temporary discounts can create a psychological discomfort among consumers, reflecting a short-term misalignment between brand trust and consumer price expectations [2] - Fulejia's official flagship store maintains price stability most of the time, only offering limited discounts during major shopping events, with prices quickly reverting post-promotion to restore the original pricing system [2] - The key objective of Fulejia's pricing strategy is to establish a clear value coordinate system, where the acceptance of price fluctuations by consumers hinges on the perceived reasonableness behind those changes [2] Group 3 - Fulejia is following a "slow is fast" growth path, focusing on sustainable brand asset development through stable pricing rather than explosive traffic strategies [3] - The ultimate goal of price management is to safeguard value rather than merely controlling numbers, integrating pricing strategies into brand building as a crucial component of consumer communication and trust accumulation [3] - The current consumer market emphasizes the importance of not sacrificing brand value for short-term sales or allowing market fluctuations to obscure value propositions, representing valuable business wisdom [3]